IMA

Conviction 32HealthcareScan · Thu, Jun 25, 2026

IMA$5.97-0.50%

ResistanceSupportVol 14Insider buy

Vol MA14 11.88K

Mar 26Apr 14May 1May 19Jun 8Jun 25

ImageneBio, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.imagenebio.com ↗

Price5.97

Change-0.50%

Gap-1.25%

Rel volume0.31×

Avg volume14.86K

Avg $ vol84.12K

SMA 205.71

SMA 505.74

SMA 2006.68

Price vs 50+4.10%

Price vs 200-10.67%

MA stackmixed

50/200 cross—

Supertrendup · 4.99

RSI (14)58

MACD hist0.05

MACD crossbull · 4d

Stoch %K / %D77 / 81

ADX (14)17

+DI / −DI21 / 14

RSI divergence—

MACD divergence—

ATR %+5.51%

ADR %5.13%

52w high17.90

52w low4.55

From 52w high-66.65%

Above 52w low+31.21%

New 52w highNo

SqueezeOn · 34d

Bollinger width14.47%

%B0.82

Donchian pos79.22%

Donchian high6.13

Donchian low5.36

AVWAP (52w high)6.49

vs AVWAP high-8.05%

AVWAP (52w low)5.92

vs AVWAP low+0.88%

OBV trendDown

Chaikin MF (20)-0.25

Today vs 20d0.31×

Avg vol (14d)11.88K

Avg vol (20d)14.86K

Avg $ vol (20d)84.12K

Market cap67.34M

RS 3m (vs SPY)-1.35%

RS 6m (vs SPY)-10.65%

RS line new highNo

Trend template—

Technical rank47.6

1 week+4.92%

1 month+2.58%

3 months+7.37%

6 months-0.17%

1 year—

YTD-11.69%

P/E-1.48

P/B0.55

P/S84.17

P/FCF-1.40

EPS-9.64

Div yield—

ROE-36.77%

ROA-33.18%

Debt/Eq0.00

Current18.39

EV/EBITDA0.18

Gross margin—

Net margin—

Rev growth-77.14%

EPS growth-24.01%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value-8.71M

Revenue800K

Net income-10.62M

Gross profit—

Free cash flow-48.26M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out11.28M

Employees17

ListedMon, Jul 28, 2025

Free float8.51M

Float %79.8%

Short interest445.33K

Days to cover28.4d

Short volume16.5%

Squeeze score35 / 100

Next earningsThu, Jul 23, 2026 (28d)

EPS forecast−$0.90 · 2 est

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction32 / 100

Pattern quality—

Tech rank47.6 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance6.17

Support5.18

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in IMA

All disclosures →

No recent disclosed trades by Congress in IMA. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in IMA · 8 buys

Insider	Side	Shares	Value	Traded	Filed
Bonita David P Director · Stock Option (right to buy) · 2026-06-16	Grant	15.6K	—	2026-06-16	2026-06-18
SLATTERY JOSEPH P Director · Stock Option (right to buy) · 2026-06-16	Grant	15.6K	—	2026-06-16	2026-06-18
Stampacchia Otello Director · Stock Option (right to buy) · 2026-06-16	Grant	15.6K	—	2026-06-16	2026-06-18
Wang Jonathan Jian Director · Stock Option (right to buy) · 2026-06-16	Grant	15.6K	—	2026-06-16	2026-06-18
Bonita David P Director · Pre-Funded Warrants (right to buy) · 2026-04-14	Buy	384.69K	—	2026-04-14	2026-04-16
OrbiMed Capital GP VI LLC Director · Common Stock · 2026-04-14	Other	—	—	2026-04-14	2026-04-16
OrbiMed Capital GP VI LLC Director · Pre-Funded Warrants (right to buy) · 2026-04-14	Buy	384.69K	—	2026-04-14	2026-04-16
OrbiMed Capital GP VI LLC Director · Pre-Funded Warrants (right to buy) · 2026-04-14	Buy	336.6K	—	2026-04-14	2026-04-16
Bonita David P Director · Pre-Funded Warrants (right to buy) · 2026-04-14	Buy	336.6K	—	2026-04-14	2026-04-16
ORBIMED ADVISORS LLC Director · Common Stock · 2026-04-14	Other	—	—	2026-04-14	2026-04-16

SEC filings

EDGAR filings in IMA · 2 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.